Mankind Pharma said it was collaborating with OpenAI to institutionalize AI across its value chain.
Mankind will integrate OpenAI Enterprise across multiple functions, including field force enablement, digital marketing, research and development (R&D), manufacturing, and medical affairs, the company said.
“In a rapidly evolving healthcare landscape, the ability to transform vast volumes of data into actionable insights, ensure fast and compliant communication, and streamline complex operations is no longer optional—it’s mission-critical. The integration of ChatGPT Enterprise internally addresses these critical needs by empowering Mankind Pharma to leverage OpenAI’s latest models, including GPT-5 to unlock efficiencies and introduce innovative solutions across its entire value chain, from discovery to delivery,” the note added.
Arjun Juneja, Mankind Pharma’s Chief Operating Officer, said collaborating with OpenAI was pivotal in building the pharma organization of the future.
“By integrating advanced AI into our core operations, we’re enabling our teams to move faster, work smarter, and unlock insights that drive real-world impact – whether it’s in field force effectiveness, supply chain agility, or R&D acceleration. This is not just about automation; it’s about creating a more responsive, intelligent, and future-ready enterprise.”
The company said, the integration of OpenAI capabilities would improve operations through smarter decision-making -”GPT-powered dashboards providing real-time, data-driven insights across R&D, supply chain, and commercial operations”; faster compliant communication – “automated, multilingual content for healthcare professionals and patients, ensuring speed, accuracy and regulatory compliance” and redefining manufacturing, for example, “using AI to analyze batch records and sensor data, detecting anomalies early and recommending corrective actions with unmatched accuracy.”
Since July 2025, Mankind Pharma has deployed customized GPTs across its workforce, enhancing the effectiveness of sales and marketing teams, it said.
“A Custom GPT in ChatGPT allows teams to create tailored AI assistants using GPT models. It enables users to define the AI’s personality, tone, and specialised knowledge base, and integrate proprietary data or workflows. This makes it possible to build AI solutions for specific industries, company needs, or creative applications without requiring advanced coding expertise,” the company explained.
“By integrating advanced AI into areas like research, operations, and medical communications, Mankind is taking meaningful steps to improve efficiency and support innovation,” said Oliver Jay, Managing Director, International at OpenAI, in the Mankind Pharma statement.
Published on September 17, 2025